June 2010 Launching of EllaOne in Cyprus
Arriani Pharmaceuticals S.A. in collaboration with the Papaellinas Group launches in Cyprus the new pharmaceutical product EllaOne, of the French company HRA Pharma. EllaOne is indicated for emergency contraception, within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure.
June 2010 Arriani Pharmaceuticals S.A. participates in the 9th European Congress on Epileptology in Rhodes
Arriani Pharmaceuticals S.A. was a strong participant in the 9th European Congress on Epileptology, which took place on the island of Rhodes in late June 2010. Specifically, its partner EISAI Ltd. was one of the major sponsors of the Congress.
May 2010 Arriani Pharmaceuticals S.A. expands its collaboration with Bonyf in Cyprus
After five years of Arriani Pharmaceuticals S.A. successfully working with the Oral Care Specialist Company Bonyf, the two companies decided to expand their collaboration in order to launch the Bonyf line in Cyprus, where the products will be marketed by the Papaellinas Group.
May 2010 2nd Cycle of Phytotherapy Seminars in the Pharmacy School of the University of Athens
Following the resounding success of the seminars organized for the first time in 2009, Arriani Pharmaceuticals S.A. organizes for a consecutive year the extremely popular seminars in phytotherapy in collaboration with the Pharmacy School of the University of Athens. These seminars are targeted for pharmacists who wish to develop the phytotherapy segment within their pharmacy and offer an alternative treatment to modern consumers.
March 2010 New Collaboration with Eisai Ltd.
Arriani Pharmaceuticals S.A. expands its collaboration with the Japanese company Eisai Ltd and prepares the launching of two innovative pharmaceutical products; the novel antiepileptic pharmaceutical product Zebinix, which is administered as adjunctive therapy in adults with partial-onset seizures, with or without secondary generalization and also the only available Botulinum toxin B product Neurobloc, for the treatment of cervical dystonia.
January 2010 Launching of Zonegran and Inovelon in Cyprus
Zonegran and Inovelon of the company Eisai are launched in Cyprus by Arriani Pharmaceuticals S.A. in collaboration with Medilink. Zonegran is indicated for add-on to existing epilepsy treatment in adult patients who have partial seizures and Inovelon for the treatment of patients aged 4 years or older who have Lennox-Gastaut syndrome.
January 2010 Collaboration Renewal with IPSEN
After five consecutive and successful years of collaboration, Arriani Pharmaceuticals S.A. and Ipsen renew their agreement for the promotion of the three gastrointestinal products Tanilas, Smecta and Fortrans.
January 2010 Launching of EllaOne in Greece
Arriani Pharmaceuticals S.A. and HRA Pharma are proud to announce the launching in Greece of the new pharmaceutical product EllaOne, for emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure.
March 2009 Launching of Crystacide
In conjunction with the company Mipharm from Italy, Arriani Pharmaceuticals S.A. launches the advanced technology topical antiseptic product Crystacide, which is indicated for the treatment of skin infections attributed to microorganisms susceptible to hydrogen peroxide.
March 2009 Organization of Phytotherapy Seminars
Arriani Pharmaceuticals S.A., in collaboration with the Pharmacy School of Athens and under the support of the Pharmacists Association of Attika, organizes a series of seminars in phytotherapy. These seminars aim to expand the use of phytotherapy in Greece and train the pharmacists who are interested in developing the phytotherapy segment of their pharmacy.
February 2009 New Collaboration with Mipharm
Arriani Pharmaceuticals S.A. gladly announces the signature of the licensing agreement with the Italian company Mipharm, for the two novel technology vaginal gels Mifluor and Chlomirex.
February 2009 New Collaboration with Kwizda
Arriani Pharmaceuticals S.A. has the pleasure to announce the signature of the distribution agreement with the company Kwizda from Austria, for the re-launching of the ethical product Noforit for dementia.
January 2009 Launching of Inaden
Arriani Pharmaceuticals S.A. is delighted to present the new INADEN oral hygiene line of the Swiss company Aileron Pharmaceuticals S.A., which offers products that cover the needs of contemporary medical practices and consumer requirements in the oral hygiene field.
December 2008 New Collaboration with Eisai Pharmaceuticals
Arriani Pharmaceuticals S.A. has the pleasure to announce its collaboration with the Japanese pharmaceutical company Eisai Ltd, with the scope to market in Greece and Cyprus the innovative pharmaceutical products Zonegran for add-on to existing epilepsy treatment in adult patients who have partial seizures, Inovelon for the treatment of patients aged 4 years or older who have Lennox-Gastaut syndrome and Prialt for the treatment of severe or chronic pain in patients who need a painkiller by intrathecal injection.
November 2008 New Collaboration and launching of Tecnoskin
Arriani Pharmaceuticals S.A. is proud to announce its collaboration with the Swiss company Aileron Pharmaceuticals S.A., with the aim to market the dermocosmetic product range Tecnoskin, created to satisfy the need of modern women for high technology action.
September 2008 New Collaboration with Mipharm
Arriani Pharmaceuticals S.A. is delighted to announce the signature of the distribution agreement with the company Mipharm from Italy, for the marketing of the product Crystacide in Greece.
September 2008 New Collaboration with HRA Pharma
After the successful collaboration with HRA Pharma for the product Lysodren, Arriani Pharmaceuticals S.A. proudly announces the signature of a new distribution agreement with the French company, for the marketing of the novel product EllaOne, for emergency contraception in Greece and Cyprus.
May 2008 Launching of Solu-ket
Arriani Pharmaceuticals S.A. launches the first topical anti-inflammatory solution for tonsillitis, stomatitis etc. in the Greek market under the name SOLU-KETฎ, licensed by Dompe Italy.
March 2008 New Collaboration with KIN
Arriani Pharmaceuticals S.A., with vast experience in the Greek dental market, announces its new collaboration with the Spanish company Laboratorios Kin, for the launching of its oral care portfolio in Greece and Cyprus.
November 2007 Launching of Hedrin in Greece
Arriani Pharmaceuticals S.A. launches the novel anti-lice treatment Hedrin from Thornton & Ross in Greece. The launch will be backed up by extensive campaigning towards pharmacies and final consumers.
October 2007 Launching of Arvifax in Greece
Arriani Pharmaceuticals S.A. launches Arvifax and Arvifax XR, the first generic product of venlafaxine in Greece. Arvifax XR is a patented tablet formulation, in contrast with the capsule form of the original venlafaxine product.
August 2007 New Collaboration with Thornton & Ross
Arriani Pharmaceuticals S.A. has the pleasure to announce the signature of the licensing agreement with the company Thornton and Ross from the UK, for the launching of the novel anti-lice product Hedrin in Greece. The product has a patented formulation of non chemical pesticides and is able to kill both lice and eggs in 30 minutes.
February 2007 New Collaboration with URGO
Arriani Pharmaceuticals S.A. is proud to announce the signature of the distribution agreement with the French company Urgo, for the launching of its OTC portfolio in Greece.
November 2006 New Collaboration with HRA Pharma
Arriani Pharmaceuticals S.A. is glad to announce its collaboration with the French company HRA Pharma, established with the aim to promote Lysodren, a pharmaceutical product treating the adrenal corticoid carcinoma.
October 2006 - New Collaboration with NEW Pharma
Arriani Pharmaceuticals S.A. gladly announces its collaboration with the Swiss company New Pharma in Switzerland, Greece and Cyprus. The first products of the collaboration will be launched in early 2007.
October 2006 Arriani Pharmaceuticals S.A. participates in the Hellenic Dentist Convention in Athens
Arriani Pharmaceuticals S.A. participated in the Pan-Hellenic Dentist Convention, which took place at the Athens Concert Hall in October 2006.
October 2006 Arriani Pharmaceuticals S.A. participates in the European Dermatology Convention in Rhodes (EADV)
Arriani Pharmaceuticals S.A. participated successfully in the European Dermatology Convention, which took place on the island of Rhodes in early October 2006.
